BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10738904)

  • 1. Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride.
    Saraswathi V; Mathuram V; Subramanian S; Govindasamy S
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):79-88. PubMed ID: 10738904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inducers and aging on rabbit liver microsomal drug-metabolizing enzymes.
    Chiang JY; DiLella AG; Steggles AW
    Mol Pharmacol; 1983 Jan; 23(1):244-51. PubMed ID: 6408388
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
    Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
    J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of fat deficiency on hepatic and pulmonary drug metabolizing enzymes in rat and mouse.
    Koul IB; Koul A; Gandhi RK; Sharma RR; Khanduja KL
    Biochem Int; 1990; 20(5):979-89. PubMed ID: 2112386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the incubation mixtures for the in vitro mutagenesis test with metabolic activation (microsomal assay) = 2. Behaviour of cytochromes P-450, P-420, b5, of NADPH-CYT. C-reductases, and p-nitroanisole demethylase.
    Bauer C; Leporini C; Bronzetti G; Nieri R; Tonarelli S; Corsi C; Del Carratore R
    Boll Soc Ital Biol Sper; 1981 Jan; 57(1):70-5. PubMed ID: 6788052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arecoline on phase I and phase II drug metabolizing system enzymes, sulfhydryl content and lipid peroxidation in mouse liver.
    Singh A; Rao AR
    Biochem Mol Biol Int; 1993 Jul; 30(4):763-72. PubMed ID: 8401332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride.
    Saraswathi V; Ramamoorthy N; Subramaniam S; Mathuram V; Gunasekaran P; Govindasamy S
    Chemotherapy; 1998; 44(3):198-205. PubMed ID: 9612610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of echitamine chloride on methylcholonthrene induced fibrosarcoma in rats.
    Kamarajan P; Sekar N; Mathuram V; Govindasamy S
    Biochem Int; 1991 Oct; 25(3):491-8. PubMed ID: 1805793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivo.
    Jagetia GC; Baliga MS
    Phytother Res; 2006 Feb; 20(2):103-9. PubMed ID: 16444661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.
    Tydén E; Olsén L; Tallkvist J; Tjälve H; Larsson P
    Res Vet Sci; 2008 Aug; 85(1):80-5. PubMed ID: 17980394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
    Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
    Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal influence of Chlorella vulgaris (E-25) on hepatic drug metabolizing enzymes and lipid peroxidation.
    Singh A; Singh SP; Bamezai R
    Anticancer Res; 1998; 18(3A):1509-14. PubMed ID: 9673362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of xenobiotic metabolizing enzymes by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in Sprague-Dawley rats.
    Chakraborty A; Selvaraj S
    Neoplasma; 2000; 47(2):81-9. PubMed ID: 10985472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
    Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
    Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the modulatory influence of food additive-garam masala on hepatic detoxication system.
    Singh A; Rao AR
    Indian J Exp Biol; 1992 Dec; 30(12):1142-5. PubMed ID: 1294478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz(a)anthracene-induced breast cancer in female rats.
    Padmavathi R; Senthilnathan P; Sakthisekaran D
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):349-54. PubMed ID: 16720105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.